Climb Bio (NASDAQ:CLYM) outlined its strategy and upcoming clinical milestones during a fireside chat at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference, with Chief Medical Officer Edgar ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (LGVN) (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and ...

Bio-Path Holdings will host a conference call on May 29, 2025, to discuss its business overview and pipeline developments. Bio-Path Holdings, Inc., a biotechnology company focused on developing cancer ...

Kelowna, British Columbia – June 5, 2025 –TheNewswire -Lexaria Bioscience Corp. (LEXX) (Nasdaq: LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that ...

The two-day event brought together a mix of researchers, startup founders and industry professionals in the Maryland life sciences community. Conference panelists. Today, the Maryland Tech Council ...

Entera Bio Ltd. (NASDAQ: ENTX) ('Entera' or the 'Company'), a leader in the development of oral peptide and protein replacement therapies, today announced that the Company’s Chief Executive Officer, ...

The company’s reliance on future clinical trial results introduces significant uncertainty regarding the potential success of its drug candidates, highlighting risks that may deter investors. The ...

THRiVE is Virginia Bio’s largest statewide event. It is a conference that brings together the leading researchers from biomedical research universities and health systems, entrepreneurs, startups and ...

MINNEAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 a.m.